656
Participants
Start Date
December 19, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
September 30, 2026
Ovaprene
Non-hormonal intravaginal ring
COMPLETED
Columbia University, New York
ACTIVE_NOT_RECRUITING
Einstein College of Medicine, The Bronx
ACTIVE_NOT_RECRUITING
Magee-Women's Hospital, Pittsburgh
ACTIVE_NOT_RECRUITING
University of Pennsylvania Penn Obstetric Gynecology Associates, Philadelphia
COMPLETED
The Johns Hopkins University, Baltimore
COMPLETED
Eastern Virginia Medical School, Norfolk
RECRUITING
Carolina Women's Research and Wellness Center, Durham
ACTIVE_NOT_RECRUITING
Emory University, Atlanta
COMPLETED
Case Western, Cleveland
ACTIVE_NOT_RECRUITING
University of Cincinnati, Cincinnati
ACTIVE_NOT_RECRUITING
Washington University, St Louis
RECRUITING
Praetorian Pharmaceutical Research, LLC, Marrero
ACTIVE_NOT_RECRUITING
University of Colorado Denver, Aurora
ACTIVE_NOT_RECRUITING
University of Utah, Salt Lake City
RECRUITING
Precision Trials AZ, Phoenix
RECRUITING
Del Sol Research Management, LLC, Tucson
ACTIVE_NOT_RECRUITING
Essential Access Health, Los Angeles
WITHDRAWN
University of California, San Francisco, San Francisco
COMPLETED
Essential Health Access (Berkeley), Berkeley
COMPLETED
University of California at Davis, Sacramento
ACTIVE_NOT_RECRUITING
University of Hawaii, Honolulu
ACTIVE_NOT_RECRUITING
Oregon Health and Science University, Portland
RECRUITING
Seattle Clinical Research Center, Seattle
ACTIVE_NOT_RECRUITING
Boston Medical Center, Boston
COMPLETED
Rutgers Medical Center, Newark
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Daré Bioscience, Inc.
INDUSTRY